Autophagy and its implication in Chinese hamster ovary cell culture
Abstract
Chinese hamster ovary (CHO) cells, that are widely used for production of therapeutic proteins, are subjected to apoptosis and autophagy under the stresses induced by conditions such as nutrient deprivation, hyperosmolality and addition of sodium butyrate. To achieve a cost-effective level of production, it is important to extend the culture longevity. Until now, there have been numerous studies in which apoptosis of recombinant CHO (rCHO) cells was inhibited, resulting in enhanced production of therapeutic proteins. Recently, autophagy in rCHO cells has drawn attention because it can be genetically and chemically controlled to increase cell survival and productivity. Autophagy is a global catabolic process which involves multiple pathways and genes that regulate the lysosomal degradation of intracellular components. A simultaneous targeting of anti-apoptosis and pro-autophagy could lead to more efficient protection of cells from stressful culture conditions. In this regard, it is worthwhile to have a detailed understanding of the autophagic pathway, in order to select appropriate genes and chemical targets to manage autophagy in rCHO cells, and thus to enhance the production of therapeutic proteins.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Anti-autophagy engineering and metabolic engineering have been used in order to optimize recombinant protein production in mammalian cells.
“Among these approaches, anti-autophagy engineering and metabolic engineering have been used in order to optimize recombinant protein production in mammalian cells (for a detailed review on the topic see (Kim et al., 2012;Kim et al., 2013)).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Kim et al., 2013
Cites
Rabinowitz, J. D., & White, E. (2010) · Science · doi:10.1126/science.1193497 · Cited by 1,982 · see citing works
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., & Tashiro, Y. (1998) · Cell Structure and Function · doi:10.1247/csf.23.33 · Cited by 1,312 · see citing works
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Williams, A., Sarkar, S., Cuddon, P., Ttofi, E. K., Saiki, S., Siddiqi, F. H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.79 · Cited by 800 · see citing works
Dual Role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation
Wei, Y., Sinha, S. C., & Levine, B. (2008) · Autophagy · doi:10.4161/auto.6788 · Cited by 424 · see citing works
Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
Balgi, A. D., Fonseca, B. D., Donohue, E., Tsang, T. C. F., Lajoie, P., Proud, C. G., Nabi, I. R., & Roberge, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007124 · Cited by 344 · see citing works
Kondo, Y., & Kondo, S. (2006) · Autophagy · doi:10.4161/auto.2.2.2463 · Cited by 305 · cited 3× · see citing works
“P53 Tumor suppressor Kondo and Kondo (2006)”
BackgroundInfluentialJiang, Z., & Sharfstein, S. T. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21726 · Cited by 118 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296 · see citing works
Aghamohseni, H., Ohadi, K., Spearman, M., Krahn, N., Moo-Young, M., Scharer, J. M., Butler, M., & Budman, H. M. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.05.024 · Cited by 75 · see citing works
- Authors
- Kim, Y. J., Baek, E., Lee, J. S., & Lee, G. M.
- Affiliations
- Korea Advanced Institute of Science and Technology (KR)
- Corresponding author
- Lee, Gyun Min
- Venue
- Biotechnology Letters
- Published
- 2013-07-24
- Volume
- 35
- Issue
- 11
- Pages
- 1753-1763
- ISSN
- 0141-5492 (ISSN-L)
- 1573-6776
- OpenAlex
- W1977960203
- Cited by
- 40
- References
- 7
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 4
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Biotechnology Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- autophagy, CHO cells, recombinant CHO cells, therapeutic protein production, apoptosis, nutrient deprivation, hyperosmolarity, sodium butyrate, lysosomal degradation, apoptosis inhibition, autophagy regulation
- MeSH terms
- Animals, Autophagy, Biotechnology, Cricetulus, Epithelial Cells, Female, CHO Cells, Apoptosis, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review